AI assistant
BIO-TECHNE Corp — Director's Dealing 2014
Apr 1, 2014
30718_dirs_2014-04-01_9193f03f-5d2b-4d0c-9f6b-7215fbffcc51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-04-01
Reporting Person: Hippel James (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-01 | Stock Option (Right to Buy) | $86.25 | A | 25000 | Acquired | 2021-04-01 | Common Stock (25000) | Direct |
| 2014-04-01 | Stock Option (Right to Buy) | $86.25 | A | 10000 | Acquired | 2021-04-01 | Common Stock (10000) | Direct |
| 2014-04-01 | Restricted Stock Units | $ | A | 5000 | Acquired | Common Stock (5000) | Direct |
Footnotes
F1: Vests 6,250 shares on each of April 1, 2015, April 1, 2016, April 1, 2017 and April 1, 2018.
F2: This performance based stock option award will vest if, and only if, certain performance goals are achieved, which performance goals will be established by the Executive Compensation Committee within 60 days of the grant date.
F3: Each restricted stock unit represents a contingent right to receive one share of Techne Corporation common stock.
F4: The restricted stock units vest in three equal annual installments beginning March 31, 2015. Shares will be delivered to the reporting person following vesting.